Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Typically administered via subcutaneous injection in experimental settings, it is now available in a breakthrough capsule formula with high oral bioavailability
If rash, burning or inflammation occur, immediately remove the product from skin and discontinue all further use.
The check-in process varies depending on how you scheduled your appointment: If you made your appointment online: Check in using the email or text message we sent to confirm your appointment
The FDA warns that both CJC-1295 and ipamorelin carry risks of immunogenicity (triggering immune responses) and cardiovascular effects, including "increased heart rate and systemic vasodilatory reaction." One clinical trial of CJC-1295 was discontinued following a participants death, though the attending physician believed the event was "unrelated to treatment." Neither CJC-1295 nor ipamorelin is FDA-approved
What is the dosing for compounded semaglutide
